Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchProton Pump InhibitorsPPIs (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19

Wu et al., Journal of Global Health, doi:10.7189/jogh.12.05005
Feb 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -197% Improvement Relative Risk Viral clearance -10% Proton Pump Inhibitors  Wu et al.  Prophylaxis Is prophylaxis with proton pump inhibitors beneficial for COVID-19? Retrospective 4,634 patients in China Higher mortality (p=0.0004) and worse viral clearance (p=0.024) c19early.org Wu et al., J. Global Health, February 2022 FavorsPPIs Favorscontrol 0 0.5 1 1.5 2+
PPIs for COVID-19
1st treatment shown to increase risk in September 2020, now with p = 0.00000012 from 39 studies.
5,100+ studies for 112 treatments. c19early.org
Retrospective 4,634 hospitalized COVID-19 patients in China, showing higher mortality and slower viral clearance with proton pump inhibitor (PPI) use. Authors hypothesize that PPIs may increase susceptibility to COVID-19 by increasing ACE2 expression.
risk of death, 197.0% higher, OR 2.97, p < 0.001, treatment 1,046, control 3,588, propensity score weighting, model 4, RR approximated with OR.
risk of no viral clearance, 9.9% higher, HR 1.10, p = 0.02, treatment 1,046, control 3,588, inverted to make HR<1 favor treatment, propensity score matching, Cox proportional hazards.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Wu et al., 19 Feb 2022, retrospective, China, peer-reviewed, 8 authors. Contact: hejia63@yeah.net, wucheng@smmu.edu.cn.
This PaperPPIsAll
Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19
Shengyong Wu, Zhichao Jin, Chi Peng, Dongdong Li, Yi Cheng, Ronghui Zhu, Professor Jia He, Professor Cheng Wu
Journal of Global Health, doi:10.7189/jogh.12.05005
Background The adverse effects of proton pump inhibitors (PPIs) on pneumonia have been well reported. However, the relationship between the use of PPIs and the adverse outcomes of coronavirus disease 2019 (COVID-19) is currently inconclusive. In this study, we aimed to explore the relationship between the use of PPIs and the in-hospital mortality among patients who were laboratory-confirmed SARS-CoV-2. Methods Data was derived from 2 hospitals which both were the first batch of SARS-CoV-2 specialist hospitals with four types of sensitivity analyses. This cohort included 4634 patients older than 18 years who were laboratory-confirmed SARS-CoV-2. Endpoints were death in hospital (primary) and the recovery of COVID-19 (secondary: the time of COVID-19 nucleic acid testing turning negative). Results In the entire cohort, there were 3588 non-users, 399 ≤ 0.5 defined daily dose (DDD) PPIs users, 483 1 DDD users, and 164 ≥ 1.5 DDD users. The multivariate logistic regression analysis (odds ratio (OR) = 3.63, 95% confidence interval (CI) = 1.83-7.23, P = 0.0002) and four types of sensitivity analyses showed higher mortality in patients using PPIs during hospitalization, while the relationship between different PPIs dosages and the hospital mortality remained insignificant. Usage of the PPIs significantly prolongs the time of COVID-19 nucleic acid testing turning negative. Conclusions The use of PPIs may increase the risk of in-hospital death of patients who were laboratory-confirmed SARS-CoV-2, which means that physicians may need to re-evaluate the benefit-risk assessment of the use of PPIs during the COVID-19 pandemic.
Authorship contributions: JH, CW and SW designed research, developed the analysis plan, and obtained the funding. ZJ and CP collated and curated all data. SW analyzed the data. All authors contributed to collect relevant literature and revise the manuscript. All authors were involved in the finalization of the manuscript and all approved the final version for submission for publication. SW, and ZJ authors contributed equally to the study. All authors read and approved the final manuscript. Competing interests: The authors have completed the ICMJE Declaration of Interest form (available upon request from the corresponding authors) and declare they have no competing interests. Additional material Online Supplementary Document
References
Arendse, Danser, Poglitsch, Touyz, Burnett et al., Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure, Pharmacol Rev, doi:10.1124/pr.118.017129
Blanco, Ambrosioni, Garcia, Martínez, Soriano et al., COVID-19 in patients with HIV: clinical case series, Lancet HIV, doi:10.1016/S2352-3018(20)30111-9
Dai, Liu, Liu, Zhou, Li et al., Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak, Cancer Discov
Du, Tu, Zhu, Mu, Wang et al., Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study, Am J Respir Crit Care Med, doi:10.1164/rccm.202003-0543OC
Effenberger, Grabherr, Mayr, Schwaerzler, Nairz et al., Faecal calprotectin indicates intestinal inflammation in COVID-19, Gut, doi:10.1136/gutjnl-2020-321388
Feng, Ling, Bai, Xie, Huang et al., COVID-19 with Different Severities: A Multicenter Study of Clinical Features, Am J Respir Crit Care Med, doi:10.1164/rccm.202002-0445OC
Goel, Gupta, Kolte, Khera, Fonarow et al., Outcomes and Temporal Trends of Inpatient Percutaneous Coronary Intervention at Centers With and Without On-site Cardiac Surgery in the United States, JAMA Cardiol, doi:10.1001/jamacardio.2016.4188
Grasselli, Pesenti, Cecconi, Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response, JAMA, doi:10.1001/jama.2020.4031
Grasselli, Zangrillo, Zanella, Antonelli, Cabrini et al., Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy, JAMA, doi:10.1001/jama.2020.5394
Guan, Liang, Zhao, Liang, Chen et al., Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, doi:10.1183/13993003.00547-2020
Gupta, Kolte, Khera, Goel, Aronow et al., Management and Outcomes of ST-Segment Elevation Myocardial Infarction in US Renal Transplant Recipients, JAMA Cardiol, doi:10.1001/jamacardio.2016.5131
Hariyanto, Prasetya, Kurniawan, Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection, Dig Liver Dis, doi:10.1016/j.dld.2020.10.001
Haudebourg, Perier, Tuffet, De Prost, Razazi et al., Respiratory Mechanics of COVID-19-versus Non-COVID-19-associated Acute Respiratory Distress Syndrome, Am J Respir Crit Care Med, doi:10.1164/rccm.202004-1226LE
Hoffmann, Kleine-Weber, Schroeder, Krüger, Herrler et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, doi:10.1016/j.cell.2020.02.052
Kurlander, Rubenstein, Richardson, Krein, Vries et al., Physicians' Perceptions of Proton Pump Inhibitor Risks and Recommendations to Discontinue: A National Survey, Am J Gastroenterol, doi:10.14309/ajg.0000000000000558
Lebreton, Dorgham, Quentric, Combes, Gorochov et al., Longitudinal Cytokine Profiling in Severe COVID-19 Patients on ECMO and Haemoadsorption, Am J Respir Crit Care Med, doi:10.1164/rccm.202011-4140LE
Lee, Ha, Yeniova, Moon, Kim et al., Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching, Gut, doi:10.1136/gutjnl-2020-322248
Lighter, Phillips, Hochman, Sterling, Johnson et al., Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission, Clin Infect Dis, doi:10.1093/cid/ciaa415
Lilly, Aljawadi, Badawi, Onukwugha, Tom et al., Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 Receptor Blockers for Preventing Clinically Important Gastrointestinal Bleeding During Intensive Care: A Population-Based Study, Chest, doi:10.1016/j.chest.2018.05.015
Lin, Jiang, Zhang, Huang, Zhang et al., Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection, Gut, doi:10.1136/gutjnl-2020-321013
Lipworth, Kuo, Lipworth, Chan, Inhaled Corticosteroids and COVID-19, Am J Respir Crit Care Med, doi:10.1164/rccm.202005-2000LE
Luxenburger, Sturm, Biever, Rieg, Duerschmied et al., Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID-19: coincidence or underestimated risk factor?, J Intern Med, doi:10.1111/joim.13121
Maclaren, Reynolds, Allen, Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit, JAMA Intern Med, doi:10.1001/jamainternmed.2013.14673
Monteleone, Sarzi-Puttini, Ardizzone, Preventing COVID-19-induced pneumonia with anticytokine therapy, Lancet Rheumatol, doi:10.1016/S2665-9913(20)30092-8
Rosenberg, Dufort, Udo, Wilberschied, Kumar et al., Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State, JAMA, doi:10.1001/jama.2020.8630
Scarpignato, Gatta, Zullo, Blandizzi, Effective and safe proton pump inhibitor therapy in acid-related diseases -A position paper addressing benefits and potential harms of acid suppression, BMC Med, doi:10.1186/s12916-016-0718-z
Schumock, Li, Suda, Wiest, Stubbings et al., National trends in prescription drug expenditures and projections for 2016, Am J Health Syst Pharm, doi:10.2146/ajhp160205
Sharif-Askari, Sharif-Askari, Alabed, Tayoun, Loney et al., Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue, Clin Transl Sci, doi:10.1111/cts.12862
Thomas, Leuppi-Taegtmeyer, Jamiolkowski, Steveling-Klein, Bellutti-Enders et al., Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities, J Allergy Clin Immunol, doi:10.1016/j.jaci.2020.07.008
Woo, Lee, Koh, Kim, Han et al., Incidence of cancer after asthma development: 2 independent population-based cohort studies, J Allergy Clin Immunol, doi:10.1016/j.jaci.2020.04.041
Wu, Mcgoogan, Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, JAMA, doi:10.1001/jama.2020.2648
Yang, Yu, Xu, Shu, Xia et al., Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, doi:10.1016/S2213-2600(20)30079-5
Zhang, Rostami, Leopold, Mezey, 'beirne et al., Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium, Am J Respir Crit Care Med, doi:10.1164/rccm.202003-0541OC
Zhou, Li, Zhao, Chu, Wang et al., Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus, Sci Adv, doi:10.1126/sciadv.aao4966
{ 'indexed': {'date-parts': [[2024, 7, 18]], 'date-time': '2024-07-18T09:50:24Z', 'timestamp': 1721296224016}, 'reference-count': 35, 'publisher': 'International Society of Global Health', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.7189/jogh.12.05005', 'type': 'journal-article', 'created': {'date-parts': [[2022, 2, 16]], 'date-time': '2022-02-16T17:55:19Z', 'timestamp': 1645034119000}, 'source': 'Crossref', 'is-referenced-by-count': 7, 'title': 'Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with ' 'COVID-19', 'prefix': '10.7189', 'volume': '12', 'author': [ {'given': 'Shengyong', 'family': 'Wu', 'sequence': 'first', 'affiliation': []}, {'given': 'Zhichao', 'family': 'Jin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Chi', 'family': 'Peng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Dongdong', 'family': 'Li', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yi', 'family': 'Cheng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ronghui', 'family': 'Zhu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jia', 'family': 'He', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cheng', 'family': 'Wu', 'sequence': 'additional', 'affiliation': []}], 'member': '4223', 'published-online': {'date-parts': [[2022, 2, 19]]}, 'reference': [ { 'key': 'key-10.7189/jogh.12.05005-202202161842-R1', 'doi-asserted-by': 'publisher', 'first-page': '1574', 'DOI': '10.1001/jama.2020.5394', 'article-title': 'Baseline Characteristics and Outcomes of 1591 Patients Infected With ' 'SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.', 'volume': '323', 'author': 'Grasselli', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R2', 'unstructured': 'Johns Hopkins University. Johns Hopkins experts in global public health, ' 'infectious disease, and emergency preparedness have been at the ' 'forefront of the international response to COVID-19. 2021. Available: ' 'https://coronavirus.jhu.edu/. Accessed: 11 April 2021.'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R3', 'doi-asserted-by': 'publisher', 'first-page': '2493', 'DOI': '10.1001/jama.2020.8630', 'article-title': 'Association of Treatment With Hydroxychloroquine or Azithromycin With ' 'In-Hospital Mortality in Patients With COVID-19 in New York State.', 'volume': '323', 'author': 'Rosenberg', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R4', 'doi-asserted-by': 'publisher', 'first-page': '786', 'DOI': '10.1016/j.jaci.2020.07.008', 'article-title': 'Emerging treatments in COVID-19: Adverse drug reactions including drug ' 'hypersensitivities.', 'volume': '146', 'author': 'Manjaly Thomas', 'year': '2020', 'journal-title': 'J Allergy Clin Immunol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R5', 'doi-asserted-by': 'publisher', 'first-page': '1380', 'DOI': '10.1164/rccm.202002-0445OC', 'article-title': 'COVID-19 with Different Severities: A Multicenter Study of Clinical ' 'Features.', 'volume': '201', 'author': 'Feng', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R6', 'doi-asserted-by': 'publisher', 'first-page': '1372', 'DOI': '10.1164/rccm.202003-0543OC', 'article-title': 'Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A ' 'Retrospective Observational Study.', 'volume': '201', 'author': 'Du', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R7', 'doi-asserted-by': 'publisher', 'first-page': '179', 'DOI': '10.1186/s12916-016-0718-z', 'article-title': 'Effective and safe proton pump inhibitor therapy in acid-related ' 'diseases - A position paper addressing benefits and potential harms of ' 'acid suppression.', 'volume': '14', 'author': 'Scarpignato', 'year': '2016', 'journal-title': 'BMC Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R8', 'doi-asserted-by': 'publisher', 'first-page': '1058', 'DOI': '10.2146/ajhp160205', 'article-title': 'National trends in prescription drug expenditures and projections for ' '2016.', 'volume': '73', 'author': 'Schumock', 'year': '2016', 'journal-title': 'Am J Health Syst Pharm'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R9', 'doi-asserted-by': 'publisher', 'first-page': '557', 'DOI': '10.1016/j.chest.2018.05.015', 'article-title': 'Comparative Effectiveness of Proton Pump Inhibitors vs Histamine Type 2 ' 'Receptor Blockers for Preventing Clinically Important Gastrointestinal ' 'Bleeding During Intensive Care: A Population-Based Study.', 'volume': '154', 'author': 'Lilly', 'year': '2018', 'journal-title': 'Chest'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R10', 'doi-asserted-by': 'publisher', 'first-page': '564', 'DOI': '10.1001/jamainternmed.2013.14673', 'article-title': 'Histamine-2 receptor antagonists vs proton pump inhibitors on ' 'gastrointestinal tract hemorrhage and infectious complications in the ' 'intensive care unit.', 'volume': '174', 'author': 'MacLaren', 'year': '2014', 'journal-title': 'JAMA Intern Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R11', 'doi-asserted-by': 'publisher', 'first-page': '689', 'DOI': '10.14309/ajg.0000000000000558', 'article-title': 'Physicians’ Perceptions of Proton Pump Inhibitor Risks and ' 'Recommendations to Discontinue: A National Survey.', 'volume': '115', 'author': 'Kurlander', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R12', 'doi-asserted-by': 'publisher', 'first-page': '1239', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and Important Lessons From the Coronavirus Disease ' '2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases ' 'From the Chinese Center for Disease Control and Prevention.', 'volume': '323', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R13', 'doi-asserted-by': 'publisher', 'first-page': '1545', 'DOI': '10.1001/jama.2020.4031', 'article-title': 'Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: ' 'Early Experience and Forecast During an Emergency Response.', 'volume': '323', 'author': 'Grasselli', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R14', 'doi-asserted-by': 'publisher', 'first-page': '475', 'DOI': '10.1016/S2213-2600(20)30079-5', 'article-title': 'Clinical course and outcomes of critically ill patients with SARS-CoV-2 ' 'pneumonia in Wuhan, China: a single-centered, retrospective, ' 'observational study.', 'volume': '8', 'author': 'Yang', 'year': '2020', 'journal-title': 'Lancet Respir Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R15', 'doi-asserted-by': 'publisher', 'first-page': '287', 'DOI': '10.1164/rccm.202004-1226LE', 'article-title': 'Respiratory Mechanics of COVID-19- versus Non-COVID-19-associated Acute ' 'Respiratory Distress Syndrome.', 'volume': '202', 'author': 'Haudebourg', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R16', 'doi-asserted-by': 'publisher', 'first-page': '25', 'DOI': '10.1001/jamacardio.2016.4188', 'article-title': 'Outcomes and Temporal Trends of Inpatient Percutaneous Coronary ' 'Intervention at Centers With and Without On-site Cardiac Surgery in the ' 'United States.', 'volume': '2', 'author': 'Goel', 'year': '2017', 'journal-title': 'JAMA Cardiol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R17', 'doi-asserted-by': 'publisher', 'first-page': '250', 'DOI': '10.1001/jamacardio.2016.5131', 'article-title': 'Management and Outcomes of ST-Segment Elevation Myocardial Infarction ' 'in US Renal Transplant Recipients.', 'volume': '2', 'author': 'Gupta', 'year': '2017', 'journal-title': 'JAMA Cardiol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R18', 'doi-asserted-by': 'publisher', 'first-page': '135', 'DOI': '10.1016/j.jaci.2020.04.041', 'article-title': 'Incidence of cancer after asthma development: 2 independent ' 'population-based cohort studies.', 'volume': '147', 'author': 'Woo', 'year': '2021', 'journal-title': 'J Allergy Clin Immunol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R19', 'doi-asserted-by': 'publisher', 'first-page': '539', 'DOI': '10.1124/pr.118.017129', 'article-title': 'Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and ' 'Associated Peptides in Hypertension and Heart Failure.', 'volume': '71', 'author': 'Arendse', 'year': '2019', 'journal-title': 'Pharmacol Rev'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R20', 'doi-asserted-by': 'publisher', 'first-page': '1543', 'DOI': '10.1136/gutjnl-2020-321388', 'article-title': 'Faecal calprotectin indicates intestinal inflammation in COVID-19.', 'volume': '69', 'author': 'Effenberger', 'year': '2020', 'journal-title': 'Gut'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R21', 'doi-asserted-by': 'publisher', 'first-page': '899', 'DOI': '10.1164/rccm.202005-2000LE', 'article-title': 'Inhaled Corticosteroids and COVID-19.', 'volume': '202', 'author': 'Lipworth', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R22', 'doi-asserted-by': 'publisher', 'first-page': '219', 'DOI': '10.1164/rccm.202003-0541OC', 'article-title': 'Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway ' 'Epithelium.', 'volume': '202', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R23', 'doi-asserted-by': 'publisher', 'first-page': '997', 'DOI': '10.1136/gutjnl-2020-321013', 'article-title': 'Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection.', 'volume': '69', 'author': 'Lin', 'year': '2020', 'journal-title': 'Gut'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R24', 'doi-asserted-by': 'publisher', 'first-page': '271', 'DOI': '10.1016/j.cell.2020.02.052', 'article-title': 'SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ' 'Clinically Proven Protease Inhibitor.', 'volume': '181', 'author': 'Hoffmann', 'year': '2020', 'journal-title': 'Cell'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R25', 'doi-asserted-by': 'publisher', 'first-page': '1433', 'DOI': '10.1164/rccm.202011-4140LE', 'article-title': 'Longitudinal Cytokine Profiling in Severe COVID-19 Patients on ECMO and ' 'Haemoadsorption.', 'volume': '203', 'author': 'Lebreton', 'year': '2021', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R26', 'doi-asserted-by': 'publisher', 'first-page': '1048', 'DOI': '10.1111/cts.12862', 'article-title': 'Effect of Common Medications on the Expression of SARS-CoV-2 Entry ' 'Receptors in Kidney Tissue.', 'volume': '13', 'author': 'Saheb Sharif-Askari', 'year': '2020', 'journal-title': 'Clin Transl Sci'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R27', 'doi-asserted-by': 'publisher', 'first-page': '76', 'DOI': '10.1136/gutjnl-2020-322248', 'article-title': 'Severe clinical outcomes of COVID-19 associated with proton pump ' 'inhibitors: a nationwide cohort study with propensity score matching.', 'volume': '70', 'author': 'Lee', 'year': '2021', 'journal-title': 'Gut'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R28', 'doi-asserted-by': 'publisher', 'first-page': 'e255', 'DOI': '10.1016/S2665-9913(20)30092-8', 'article-title': 'Preventing COVID-19-induced pneumonia with anticytokine therapy.', 'volume': '2', 'author': 'Monteleone', 'year': '2020', 'journal-title': 'Lancet Rheumatol'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R29', 'doi-asserted-by': 'publisher', 'first-page': 'eaao4966', 'DOI': '10.1126/sciadv.aao4966', 'article-title': 'Human intestinal tract serves as an alternative infection route for ' 'Middle East respiratory syndrome coronavirus.', 'volume': '3', 'author': 'Zhou', 'year': '2017', 'journal-title': 'Sci Adv'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R30', 'doi-asserted-by': 'publisher', 'first-page': '121', 'DOI': '10.1111/joim.13121', 'article-title': 'Treatment with proton pump inhibitors increases the risk of secondary ' 'infections and ARDS in hospitalized patients with COVID-19: coincidence ' 'or underestimated risk factor?', 'volume': '289', 'author': 'Luxenburger', 'year': '2021', 'journal-title': 'J Intern Med'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R31', 'doi-asserted-by': 'publisher', 'first-page': '1410', 'DOI': '10.1016/j.dld.2020.10.001', 'article-title': 'Proton pump inhibitor use is associated with increased risk of severity ' 'and mortality from coronavirus disease 2019 (COVID-19) infection.', 'volume': '52', 'author': 'Hariyanto', 'year': '2020', 'journal-title': 'Dig Liver Dis'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R32', 'doi-asserted-by': 'publisher', 'first-page': '2000547', 'DOI': '10.1183/13993003.00547-2020', 'article-title': 'Comorbidity and its impact on 1590 patients with COVID-19 in China: a ' 'nationwide analysis.', 'volume': '55', 'author': 'Guan', 'year': '2020', 'journal-title': 'Eur Respir J'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R33', 'doi-asserted-by': 'publisher', 'first-page': '896', 'DOI': '10.1093/cid/ciaa415', 'article-title': 'Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 ' 'Hospital Admission.', 'volume': '71', 'author': 'Lighter', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R34', 'doi-asserted-by': 'crossref', 'first-page': '783', 'DOI': '10.1158/2159-8290.CD-20-0422', 'article-title': 'Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A ' 'Multicenter Study during the COVID-19 Outbreak.', 'volume': '10', 'author': 'Dai', 'year': '2020', 'journal-title': 'Cancer Discov'}, { 'key': 'key-10.7189/jogh.12.05005-202202161842-R35', 'doi-asserted-by': 'publisher', 'first-page': 'e314', 'DOI': '10.1016/S2352-3018(20)30111-9', 'article-title': 'COVID-19 in patients with HIV: clinical case series.', 'volume': '7', 'author': 'Blanco', 'year': '2020', 'journal-title': 'Lancet HIV'}], 'container-title': 'Journal of Global Health', 'original-title': [], 'link': [ { 'URL': 'http://jogh.org/documents/2022/jogh-12-05005.pdf', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 1, 27]], 'date-time': '2023-01-27T04:15:40Z', 'timestamp': 1674792940000}, 'score': 1, 'resource': {'primary': {'URL': 'http://jogh.org/documents/2022/jogh-12-05005.pdf'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 2, 19]]}, 'references-count': 35, 'URL': 'http://dx.doi.org/10.7189/jogh.12.05005', 'relation': {}, 'ISSN': ['2047-2978', '2047-2986'], 'subject': [], 'container-title-short': 'J Glob Health', 'published': {'date-parts': [[2022, 2, 19]]}, 'article-number': '05005'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit